Technology

The Mynx VCS vascular closure system (VCD) by AccessClosure designed to seal a puncture site in the femoral artery and ...

Home August 24, 2008
Home
News

August 25, 2008 - A study conducted by the Cardiovascular Research Institute, Washington Hospital Center, Washington, D ...

Home August 24, 2008
Home
News

August 22, 2008 - SonoSite Inc. said today it began customer shipments of its first major expansion of capabilities for ...

Home August 21, 2008
Home
News

August 22, 2008 – The FDA informed healthcare professionals today that the agency is investigating a report from the ...

Home August 21, 2008
Home
News

August 22, 2008 - The 23rd Annual Advances in Contrast Ultrasound: Atherosclerosis Imaging and Interventions/Bubble Course will explore applications of contrast ultrasound Sept. 18-19 at the Millennium Knickerbocker Hotel in Chicago.

Home August 21, 2008
Home
News

August 22, 2008 - St. Jude Medical Inc. this week said the FDA approved of the company’s new facility in Arecibo, Puerto Rico, for the manufacturing of pacemakers and cardiac leads.

Home August 21, 2008
Home
News

August 22, 2008 – The 21st annual Healthcare Facilities Symposium and Expo Sept. 9-11, 2008 at Navy Pier in Chicago ...

Home August 21, 2008
Home
News

August 22, 2008 - HeartWare Ltd. this week said the first patient in the U.S. received the HeartWare Left Ventricular ...

Home August 21, 2008
Home
News

August 21, 2008 – The first U.S. patient implanted with the DuraHeart Left Ventricular Assist System (LVAS) was ...

Home August 20, 2008
Home
News

August 21, 2008 - CardioECG 3.2, introduced by LUMEDX Corp. and Epiphany Cardiography Products, is a multimodality ...

Home August 20, 2008
Home
News

August 20, 2008 - Royal Philips Electronics said today it will lead a new European Union-funded research project called ...

Home August 19, 2008
Home
News

August 20, 2008 - Diagnostic testing conducted at or near the site of the patient, known as patient-side point-of-care ...

Home August 19, 2008
Home
Technology

Bracco's Isovue (iopamidol injection) X-ray/CT contrast is reportedly a safe and effective nonionic contrast agent, which is well established with U.S. clinical experience since 1986. Worldwide, more than 250 million doses of iopamidol have been administered, the company said.

Home August 19, 2008
Home
News

August 20, 2008 — FiatLux Imaging Inc. — a high-tech company founded by former Microsoft software veterans — said the ...

Home August 19, 2008
Home
Technology

FiatLux Imaging Inc. offers its FiatLux Visualize medical imaging application that capitalizes on advanced video game ...

Home August 18, 2008
Home
Subscribe Now